Envol Biomedical
Envol Biomedical is a leading nonclinical laboratory specializing in pharmacology and toxicology research using nonhuman primates. Committed to ethical standards, rapid delivery, and cutting-edge technology, Envol supports drug development and biomedical research with a focus on innovation, quality, and client success. The company is expanding its capabilities, infrastructure, and supply chain resilience to meet the growing demands of the biotech and pharmaceutical industries, aiming to transition to GLP compliance by 2025. Envol emphasizes a stable foundation, organizational stability, and a client-centered approach to navigate industry headwinds and industry challenges effectively.
Industries
Nr. of Employees
medium (51-250)
Envol Biomedical
New City, New York, United States, North America
Services
End-to-end support for preclinical pharmacology, PK/DMPK, and toxicology studies using non-human primates, including study design, surgical model execution, sample collection, and regulatory-grade reporting.
Intraprocedural image-guided neurosurgical procedures for precision delivery of therapeutics to selected brain regions, with integrated imaging feedback and placement verification.
Provision of multimodal imaging (MRI, PET, CT, SPECT, DEXA) to support surgical guidance, longitudinal anatomy/functional assessment, and biodistribution studies.
Bioanalytical assay execution, sample handling and processing to support PK, immunogenicity, pharmacology and toxicology endpoints, with access to curated biological matrices.
Implementation of a preclinical LIMS and AI-assisted analytics to standardize study execution, protocol management, colony and veterinary management, pathology/histology workflows, scheduling and regulatory data formatting (SEND).
Services to secure ethically sourced animals, manage breeding programs and supplier agreements to ensure continuity of NHP availability and reduce sourcing risk for studies.
End-to-end support for preclinical pharmacology, PK/DMPK, and toxicology studies using non-human primates, including study design, surgical model execution, sample collection, and regulatory-grade reporting.
Intraprocedural image-guided neurosurgical procedures for precision delivery of therapeutics to selected brain regions, with integrated imaging feedback and placement verification.
Provision of multimodal imaging (MRI, PET, CT, SPECT, DEXA) to support surgical guidance, longitudinal anatomy/functional assessment, and biodistribution studies.
Bioanalytical assay execution, sample handling and processing to support PK, immunogenicity, pharmacology and toxicology endpoints, with access to curated biological matrices.
Implementation of a preclinical LIMS and AI-assisted analytics to standardize study execution, protocol management, colony and veterinary management, pathology/histology workflows, scheduling and regulatory data formatting (SEND).
Services to secure ethically sourced animals, manage breeding programs and supplier agreements to ensure continuity of NHP availability and reduce sourcing risk for studies.
Expertise Areas
- Non-human primate (NHP) preclinical research
- Preclinical pharmacology and DMPK
- Preclinical toxicology and safety pharmacology
- Image-guided neurosurgical models and CNS dosing
Key Technologies
- High-field MRI (3T) and MRI-guided neuro-navigation
- PET imaging
- CT imaging
- SPECT imaging
News & Updates
Envol Biomedical welcomes Dr. Daniela Schwotzer as Director of Toxicology, strengthening its GLP toxicology services.
Early engagement with Envol Biomedical can streamline nonhuman primate preclinical studies, reducing delays and costs.
Envol Biomedical’s neurosurgery team is setting a new standard in NHP translational research through expert innovation.
Envol Biomedical welcomes Dr. Daniela Schwotzer as Director of Toxicology, strengthening its GLP toxicology services.
Early engagement with Envol Biomedical can streamline nonhuman primate preclinical studies, reducing delays and costs.
Envol Biomedical’s neurosurgery team is setting a new standard in NHP translational research through expert innovation.